Introduction to Recurrent Angioedema – State of the Art and Future Directions

Introduction to Recurrent Angioedema – State of the Art and Future Directions

Module 1 – Different Faces of Angioedema

The module presents a new comprehensive classification based on integration of phenotypes, pathomechanisms and genomics covering all types of angioedema, shows how to differentiate angioedema from mimicking clinical conditions and explains the underlying pathomechanisms.
Consequently, this module presents all angioedema syndromes in a unique classification system, the angioedema mimickers and the underlying mechanisms fulfil a highly desired necessity of clinicians coming across with angioedema.

Module 2 – Diagnosis and Clinical Management of Angioedema

This module focuses on the diagnosis, triggering factors, biomarkers and tools to be used to diagnose different angioedema endotypes. The topic is relevant to orient the therapy and to prevent inadequate approaches in patients presenting recurrent angioedema. The awareness about trigger factors, possible biomarkers and diagnostic tools can improve the management of angioedema patients.

Module 3 – Treatment of Recurrent Angioedema

This module presents the current and upcoming treatment approaches for hereditary angioedema and mast cell-driven angioedema. Current treatment of hereditary angioedema is based on four pillars: secondary prevention, on demand treatment of acute angioedema attacks, short-term prophylaxis (STP) to prevent the development of angioedema attacks in risky situations and long-term prophylaxis (LTP) to prevent acute angioedema attacks. The ultimate goals of hereditary angioedema treatment are to control the disease and normalize the patients’ life.

These educational modules are supported by unrestricted financial support form CSL-Behring, Ionis Pharmaceuticals, and Pharvaris.